These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9679912)

  • 1. Leuprolide causes pure red cell aplasia.
    Maeda H; Arai Y; Aoki Y; Okubo K; Okada T; Ueda Y
    J Urol; 1998 Aug; 160(2):501. PubMed ID: 9679912
    [No Abstract]   [Full Text] [Related]  

  • 2. Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate.
    Kobayashi M; Nukui A; Morita T
    Int J Urol; 2005 Nov; 12(11):1010-1. PubMed ID: 16351663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.
    Palmieri G; Lastoria S; Colao A; Vergara E; Varrella P; Biondi E; Selleri C; Catalano L; Lombardi G; Bianco AR; Salvatore M
    N Engl J Med; 1997 Jan; 336(4):263-5. PubMed ID: 8995089
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: a retrospective chart review.
    Curtis KK; Adam TJ; Chen SC; Pruthi RK; Gornet MK
    Aging Male; 2008 Dec; 11(4):157-61. PubMed ID: 18937151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic prostate cancer.
    Curtis KK; Pruthi RK; Fonseca R; Gornet MK
    Urology; 2007 Oct; 70(4):811.e5-8. PubMed ID: 17991572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.
    Paniagua MA; Hirsch IB
    J Gerontol A Biol Sci Med Sci; 2005 Oct; 60(10):1283-4. PubMed ID: 16282560
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment with cyclosporin A of pure red cell aplasia associated with rheumatoid arthritis.
    Fujii T; Yajima T; Kameda H; Mimori T; Akizuki M; Ikeda Y
    J Rheumatol; 1996 Oct; 23(10):1803-5. PubMed ID: 8895163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Watchful waiting beats androgen deprivation therapy in early prostate cancer.
    Brower V
    J Natl Cancer Inst; 2008 Nov; 100(21):1494-6. PubMed ID: 18957680
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
    Daskivich TJ; Oh WK
    Urology; 2006 May; 67(5):1084.e15-7. PubMed ID: 16698377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer.
    Wieder JA; Soloway MS
    J Urol; 1998 Jun; 159(6):2099. PubMed ID: 9598539
    [No Abstract]   [Full Text] [Related]  

  • 12. Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done?
    Macdougall IC; Roche A; Rossert J; Casadevall N; Francois P; Kemeny DM
    Nephrol Dial Transplant; 2004 Nov; 19(11):2901-5. PubMed ID: 15496566
    [No Abstract]   [Full Text] [Related]  

  • 13. Escitalopram in treatment of antiandrogen-related mood disturbance in a patient with chronic schizophrenia and adenocarcinoma of the prostate.
    Kao LC; Chen LF; Hsu YC; Chuang WC; Chao HL; Chang HA; Kao YC; Chen TY; Tzeng NS
    Gen Hosp Psychiatry; 2015; 37(4):e11-2. PubMed ID: 25911327
    [No Abstract]   [Full Text] [Related]  

  • 14. Interstitial pneumonitis related to leuprorelin acetate and flutamide.
    Azuma T; Kurimoto S; Mikami K; Oshi M
    J Urol; 1999 Jan; 161(1):221. PubMed ID: 10037405
    [No Abstract]   [Full Text] [Related]  

  • 15. Pituitary apoplexy after leuprolide administration for carcinoma of the prostate: what's new?
    Faustini-Fustini M
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):378. PubMed ID: 9156052
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
    Cherrier MM; Rose AL; Higano C
    J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Impact of androgen deprivation therapy on volume reduction and lower urinary tract symptoms in patients with prostate cancer.
    Shin YS; Lee DS
    Low Urin Tract Symptoms; 2020 Sep; 12(3):293-294. PubMed ID: 32924313
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermatitis herpetiformis associated with administration of a gonadotropin-releasing hormone analog.
    Yu SS; Connolly MK; Berger TG; McCalmont TH
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S58-9. PubMed ID: 16428002
    [No Abstract]   [Full Text] [Related]  

  • 19. Competing risks for patients with localized prostate cancer.
    Seidenfeld J; Samson DJ; Albertsen PC
    J Natl Cancer Inst; 2007 Oct; 99(20):1498-9. PubMed ID: 17925533
    [No Abstract]   [Full Text] [Related]  

  • 20. Knowing all the side effects.
    Dodd BA
    RN; 1997 Jan; 60(1):68. PubMed ID: 9016171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.